ELI LILLY AND COMPANY Stock-Based Compensation
ELI LILLY AND COMPANY (LLY) reported Stock-Based Compensation of $362.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- ELI LILLY AND COMPANY share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $201.00M, a 8.65% increase year-over-year.
- ELI LILLY AND COMPANY share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $161.00M, a 4.55% increase year-over-year.
- ELI LILLY AND COMPANY share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $136.10M, a 4.36% decline year-over-year.
- ELI LILLY AND COMPANY share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $150.90M, a 13.29% increase year-over-year.
- ELI LILLY AND COMPANY share-based payment arrangement, noncash expense for fiscal 2025 was $626.00M, a 3.10% decline from fiscal 2024.
- ELI LILLY AND COMPANY share-based payment arrangement, noncash expense for fiscal 2024 was $646.00M, a 2.70% increase from fiscal 2023.
- ELI LILLY AND COMPANY share-based payment arrangement, noncash expense for fiscal 2023 was $629.00M, a 69.50% increase from fiscal 2022.
- ELI LILLY AND COMPANY share-based payment arrangement, noncash expense for fiscal 2022 was $371.10M, a 8.26% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $201.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $362.00M 10-Q · filed 2026-08-05 | $498.10M derived: sum of 3 quarters · filed 2026-08-05 | $649.00M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $161.00M 10-Q · filed 2026-04-30 | $297.10M derived: sum of 2 quarters · filed 2026-04-30 | $448.00M derived: sum of 3 quarters · filed 2026-04-30 | $633.00M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $136.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $287.00M derived: sum of 2 quarters · filed 2026-02-12 | $472.00M derived: sum of 3 quarters · filed 2026-08-05 | $626.00M 10-K · filed 2026-02-12 | |||
| 2025-09-30 | $150.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $335.90M derived: sum of 2 quarters · filed 2026-08-05 | $489.90M 10-Q · filed 2025-10-30 | $632.20M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $185.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $339.00M 10-Q · filed 2026-08-05 | $338.80M 10-Q · filed 2025-08-07 | $481.30M derived: sum of 3 quarters · filed 2026-08-05 | $614.50M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $154.00M 10-Q · filed 2026-04-30 | $153.70M 10-Q · filed 2025-05-01 | $296.30M derived: sum of 2 quarters · filed 2026-04-30 | $429.50M derived: sum of 3 quarters · filed 2026-04-30 | $640.60M derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $142.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $275.50M derived: sum of 2 quarters · filed 2026-02-12 | $486.60M derived: sum of 3 quarters · filed 2026-02-12 | $646.00M 10-K · filed 2026-02-12 | $645.60M 10-K · filed 2025-02-19 | ||
| 2024-09-30 | $133.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $344.30M derived: sum of 2 quarters · filed 2025-10-30 | $503.70M 10-Q · filed 2025-10-30 | $624.40M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-06-30 | $211.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $370.50M 10-Q · filed 2025-08-07 | $491.20M derived: sum of 3 quarters · filed 2026-02-12 | $706.80M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-03-31 | $159.40M 10-Q · filed 2025-05-01 | $280.10M derived: sum of 2 quarters · filed 2026-02-12 | $495.70M derived: sum of 3 quarters · filed 2026-02-12 | $657.20M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2023-12-31 | $120.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $336.30M derived: sum of 2 quarters · filed 2026-02-12 | $497.80M derived: sum of 3 quarters · filed 2026-02-12 | $629.00M 10-K · filed 2026-02-12 | $628.50M 10-K · filed 2024-02-21 | ||
| 2023-09-30 | $215.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $377.10M derived: sum of 2 quarters · filed 2024-10-30 | $508.30M 10-Q · filed 2024-10-30 | $601.20M derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-06-30 | $161.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $292.70M 10-Q · filed 2024-08-08 | $385.60M derived: sum of 3 quarters · filed 2025-02-19 | $470.70M derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2023-03-31 | $131.20M 10-Q · filed 2024-04-30 | $224.10M derived: sum of 2 quarters · filed 2025-02-19 | $309.20M derived: sum of 3 quarters · filed 2025-02-19 | $401.30M derived: sum of 4 quarters · filed 2025-02-19 | |||
| 2022-12-31 | $92.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $178.00M derived: sum of 2 quarters · filed 2025-02-19 | $270.10M derived: sum of 3 quarters · filed 2025-02-19 | $371.10M 10-K · filed 2025-02-19 | |||
| 2022-09-30 | $85.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $177.20M derived: sum of 2 quarters · filed 2023-11-02 | $278.20M 10-Q · filed 2023-11-02 | $353.50M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $92.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $193.10M 10-Q · filed 2023-08-08 | $268.40M derived: sum of 3 quarters · filed 2024-02-21 | $358.50M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $101.00M 10-Q · filed 2023-04-27 | $176.30M derived: sum of 2 quarters · filed 2024-02-21 | $266.40M derived: sum of 3 quarters · filed 2024-02-21 | $358.30M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $75.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $165.40M derived: sum of 2 quarters · filed 2024-02-21 | $257.30M derived: sum of 3 quarters · filed 2024-02-21 | $342.80M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $90.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $182.00M derived: sum of 2 quarters · filed 2022-11-01 | $267.50M 10-Q · filed 2022-11-01 | $355.30M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $91.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $177.40M 10-Q · filed 2022-08-04 | $265.20M derived: sum of 3 quarters · filed 2023-02-22 | $336.90M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $85.50M 10-Q · filed 2022-04-29 | $173.30M derived: sum of 2 quarters · filed 2023-02-22 | $245.00M derived: sum of 3 quarters · filed 2023-02-22 | $321.80M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $87.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $159.50M derived: sum of 2 quarters · filed 2023-02-22 | $236.30M derived: sum of 3 quarters · filed 2023-02-22 | $308.10M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $71.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $148.50M derived: sum of 2 quarters · filed 2021-10-27 | $220.30M 10-Q · filed 2021-10-27 | $301.90M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2020-06-30 | $76.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $148.60M 10-Q · filed 2021-08-03 | $230.20M derived: sum of 3 quarters · filed 2022-02-23 | $305.70M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2020-03-31 | $71.80M 10-Q · filed 2021-04-30 | $153.40M derived: sum of 2 quarters · filed 2022-02-23 | $228.90M derived: sum of 3 quarters · filed 2022-02-23 | $308.40M derived: sum of 4 quarters · filed 2022-02-23 | |||
| 2019-12-31 | $81.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $157.10M derived: sum of 2 quarters · filed 2022-02-23 | $236.60M derived: sum of 3 quarters · filed 2022-02-23 | $312.40M 10-K · filed 2022-02-23 | |||
| 2019-09-30 | $75.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $155.00M derived: sum of 2 quarters · filed 2020-10-28 | $230.80M 10-Q · filed 2020-10-28 | $303.60M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-06-30 | $79.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $155.30M 10-Q · filed 2020-07-31 | $228.10M derived: sum of 3 quarters · filed 2021-02-17 | $296.60M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-03-31 | $75.80M 10-Q · filed 2020-05-01 | $148.60M derived: sum of 2 quarters · filed 2021-02-17 | $217.10M derived: sum of 3 quarters · filed 2021-02-17 | $287.30M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2018-12-31 | $72.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $141.30M derived: sum of 2 quarters · filed 2021-02-17 | $211.50M derived: sum of 3 quarters · filed 2021-02-17 | $279.50M 10-K · filed 2021-02-17 | |||
| 2018-09-30 | $68.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $138.70M derived: sum of 2 quarters · filed 2019-10-25 | $206.70M 10-Q · filed 2019-10-25 | $278.90M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-06-30 | $70.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $138.20M 10-Q · filed 2019-08-02 | $210.40M derived: sum of 3 quarters · filed 2020-02-19 | $280.30M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-03-31 | $68.00M 10-Q · filed 2019-05-02 | $140.20M derived: sum of 2 quarters · filed 2020-02-19 | $210.10M derived: sum of 3 quarters · filed 2020-02-19 | $280.00M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2017-12-31 | $72.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $142.10M derived: sum of 2 quarters · filed 2020-02-19 | $212.00M derived: sum of 3 quarters · filed 2020-02-19 | $281.30M 10-K · filed 2020-02-19 | |||
| 2017-09-30 | $69.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $139.80M derived: sum of 2 quarters · filed 2018-11-06 | $209.10M 10-Q · filed 2018-11-06 | $275.90M derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2017-06-30 | $69.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | $139.20M 10-Q · filed 2018-07-25 | $206.00M derived: sum of 3 quarters · filed 2019-10-24 | $267.50M derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2017-03-31 | $69.30M 10-Q · filed 2018-04-27 | $136.10M derived: sum of 2 quarters · filed 2019-10-24 | $197.60M derived: sum of 3 quarters · filed 2019-10-24 | $262.60M derived: sum of 4 quarters · filed 2019-10-24 | |||
| 2016-12-31 | $66.80M derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24 | $128.30M derived: sum of 2 quarters · filed 2019-10-24 | $193.30M derived: sum of 3 quarters · filed 2019-10-24 | $255.30M 8-K · filed 2019-10-24 | |||
| 2016-09-30 | $61.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $126.50M derived: sum of 2 quarters · filed 2017-10-27 | $188.50M 10-Q · filed 2017-10-27 | $246.90M derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2016-06-30 | $65.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $127.00M 10-Q · filed 2017-07-28 | $185.40M derived: sum of 3 quarters · filed 2018-02-20 | $240.10M derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2016-03-31 | $62.00M 10-Q · filed 2017-05-01 | $120.40M derived: sum of 2 quarters · filed 2018-02-20 | $175.10M derived: sum of 3 quarters · filed 2018-02-20 | $230.90M derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2015-12-31 | $58.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $113.10M derived: sum of 2 quarters · filed 2018-02-20 | $168.90M derived: sum of 3 quarters · filed 2018-02-20 | $217.80M 10-K · filed 2018-02-20 | |||
| 2015-09-30 | $54.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $110.50M derived: sum of 2 quarters · filed 2016-10-28 | $159.40M 10-Q · filed 2016-10-28 | $200.00M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-06-30 | $55.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $104.70M 10-Q · filed 2016-07-28 | $145.30M derived: sum of 3 quarters · filed 2017-02-21 | $183.80M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-03-31 | $48.90M 10-Q · filed 2016-04-29 | $89.50M derived: sum of 2 quarters · filed 2017-02-21 | $128.00M derived: sum of 3 quarters · filed 2017-02-21 | $166.60M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2014-12-31 | $40.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $79.10M derived: sum of 2 quarters · filed 2017-02-21 | $117.70M derived: sum of 3 quarters · filed 2017-02-21 | $156.00M 10-K · filed 2017-02-21 | |||
| 2014-09-30 | $38.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $77.10M derived: sum of 2 quarters · filed 2015-10-30 | $115.40M 10-Q · filed 2015-10-30 | $155.20M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-06-30 | $38.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $76.90M 10-Q · filed 2015-07-30 | $116.70M derived: sum of 3 quarters · filed 2016-02-19 | $153.00M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-03-31 | $38.30M 10-Q · filed 2015-04-30 | $78.10M derived: sum of 2 quarters · filed 2016-02-19 | $114.40M derived: sum of 3 quarters · filed 2016-02-19 | $148.00M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2013-12-31 | $39.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $76.10M derived: sum of 2 quarters · filed 2016-02-19 | $109.70M derived: sum of 3 quarters · filed 2016-02-19 | $144.90M 10-K · filed 2016-02-19 | |||
| 2013-09-30 | $36.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $69.90M derived: sum of 2 quarters · filed 2014-10-29 | $105.10M 10-Q · filed 2014-10-29 | $146.30M derived: sum of 4 quarters · filed 2015-02-19 | |||
| 2013-06-30 | $33.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-28 | $68.80M 10-Q · filed 2014-07-28 | $110.00M derived: sum of 3 quarters · filed 2015-02-19 | $144.50M derived: sum of 4 quarters · filed 2015-02-19 | |||
| 2013-03-31 | $35.20M 10-Q · filed 2014-04-28 | $76.40M derived: sum of 2 quarters · filed 2015-02-19 | $110.90M derived: sum of 3 quarters · filed 2015-02-19 | $145.80M derived: sum of 4 quarters · filed 2015-02-19 | |||
| 2012-12-31 | $41.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $75.70M derived: sum of 2 quarters · filed 2015-02-19 | $110.60M derived: sum of 3 quarters · filed 2015-02-19 | $141.50M 10-K · filed 2015-02-19 | |||
| 2012-09-30 | $34.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $69.40M derived: sum of 2 quarters · filed 2013-10-30 | $100.30M 10-Q · filed 2013-10-30 | $137.00M derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2012-06-30 | $34.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | $65.80M 10-Q · filed 2013-07-26 | $102.50M derived: sum of 3 quarters · filed 2014-02-19 | $139.00M derived: sum of 4 quarters · filed 2014-02-19 | |||
| 2012-03-31 | $30.90M 10-Q · filed 2013-04-26 | $28.20M 10-Q · filed 2012-04-30 | $67.60M derived: sum of 2 quarters · filed 2014-02-19 | $104.10M derived: sum of 3 quarters · filed 2014-02-19 | $140.40M derived: sum of 4 quarters · filed 2014-02-19 | ||
| 2011-12-31 | $36.70M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19 | $73.20M derived: sum of 2 quarters · filed 2014-02-19 | $109.50M derived: sum of 3 quarters · filed 2014-02-19 | $147.40M 10-K · filed 2014-02-19 | |||
| 2011-09-30 | $36.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-26 | $72.80M derived: sum of 2 quarters · filed 2012-10-26 | $110.70M 10-Q · filed 2012-10-26 | $166.50M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-06-30 | $36.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $74.20M 10-Q · filed 2012-07-27 | $130.00M derived: sum of 3 quarters · filed 2013-02-21 | $177.00M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-03-31 | $37.90M 10-Q · filed 2012-04-30 | $93.70M derived: sum of 2 quarters · filed 2013-02-21 | $140.70M derived: sum of 3 quarters · filed 2013-02-21 | $195.20M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2010-12-31 | $55.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $102.80M derived: sum of 2 quarters · filed 2013-02-21 | $157.30M derived: sum of 3 quarters · filed 2013-02-21 | $231.00M 10-K · filed 2013-02-21 | |||
| 2010-09-30 | $47.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $101.50M derived: sum of 2 quarters · filed 2011-10-28 | $175.20M 10-Q · filed 2011-10-28 | $279.30M derived: sum of 4 quarters · filed 2012-02-24 | |||
| 2010-06-30 | $54.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29 | $128.20M 10-Q · filed 2011-07-29 | -$128.20M 10-Q/A · filed 2010-08-02 | $232.30M derived: sum of 3 quarters · filed 2012-02-24 | $657.10M derived: sum of 4 quarters · filed 2012-02-24 | ||
| 2010-03-31 | $73.70M 10-Q · filed 2011-04-29 | -$73.70M 10-Q · filed 2010-04-30 | $177.80M derived: sum of 2 quarters · filed 2012-02-24 | $602.60M derived: sum of 3 quarters · filed 2012-02-24 | $508.30M derived: sum of 4 quarters · filed 2012-02-24 | ||
| 2009-12-31 | $104.10M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | $528.90M derived: sum of 2 quarters · filed 2012-02-24 | $434.60M derived: sum of 3 quarters · filed 2012-02-24 | $368.50M 10-K · filed 2012-02-24 | -$368.50M 10-K · filed 2010-02-22 | ||
| 2009-09-30 | $424.80M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-10-29 | $330.50M derived: sum of 2 quarters · filed 2010-10-29 | $264.40M 10-Q · filed 2010-10-29 | $327.00M derived: sum of 4 quarters · filed 2011-02-22 | |||
| 2009-06-30 | -$94.30M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-02 | -$160.40M 10-Q/A · filed 2010-08-02 | $160.40M 10-Q · filed 2009-07-31 | -$97.80M derived: sum of 3 quarters · filed 2011-02-22 | -$19.90M derived: sum of 4 quarters · filed 2011-02-22 | ||
| 2009-03-31 | -$66.10M 10-Q · filed 2010-07-30 | -$3.50M derived: sum of 2 quarters · filed 2011-02-22 | $74.40M derived: sum of 3 quarters · filed 2011-02-22 | ||||
| 2008-12-31 | $62.60M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22 | $140.50M derived: sum of 2 quarters · filed 2011-02-22 | $255.30M 10-K · filed 2011-02-22 | -$255.30M 10-K · filed 2010-02-22 | |||
| 2008-09-30 | $77.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-30 | $192.70M 10-Q · filed 2009-10-30 | |||||
| 2008-06-30 | $114.80M 10-Q · filed 2009-07-31 | ||||||
| 2007-12-31 | -$282.00M 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |